Dr. Agarwal’s Health Care Limited has announced its unaudited consolidated financial results for the half-year ended September 30, 2026. The company reported a robust 28.7% year-on-year growth in revenue from operations, reaching INR 1,269 Crores. EBITDA saw a 27.0% increase to INR 362 Crores, and Profit After Tax grew by a remarkable 50.1% to INR 112 Crores. The company also announced the re-designation of Dr. Amar Agarwal as Executive Chairman.
Strong Financial Performance in H1 FY27
Dr. Agarwal’s Health Care Limited has posted impressive financial results for the first half of the fiscal year 2027, ending September 30, 2026. The company’s Revenue from Operations surged by 28.7% year-on-year to INR 1,269 Crores, up from INR 986 Crores in the corresponding period of the previous year. Total Income also saw a significant increase of 27.6%, amounting to INR 1,286 Crores.
Profitability Boosts
EBITDA for the half-year increased by 27.0% to INR 362 Crores, with EBITDA margins standing at a healthy 28.2%. Profit After Tax (PAT) witnessed substantial growth of 50.1%, reaching INR 112 Crores compared to INR 75 Crores in H1 FY26. PAT margins improved to 8.7% from 7.4%.
Quarterly Highlights
For the second quarter of FY27 (ended September 30, 2026), Revenue from Operations grew by 31.4% to INR 655 Crores. EBITDA rose by 28.8% to INR 186 Crores, while PAT increased by 55.8% to INR 57 Crores.
Network Expansion and Operational Growth
As of September 30, 2026, the company’s network comprised 324 facilities, with 39 new centres added during the half-year. The company performed 186,923 surgeries, an 18.8% increase year-on-year. Dr. Adil Agarwal, CEO, highlighted the significant growth driven by mature hospitals and the addition of advanced surgical facilities.
Leadership Appointment
In a key corporate development, Dr. Amar Agarwal has been appointed and re-designated as the Executive Chairman (Whole-Time Director) of the Company, effective November 01, 2026, for a period of three years. This change follows the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited.
Source: BSE
